Technical Analysis for ARCT - Arcturus Therapeutics Ltd.

Grade Last Price % Change Price Change
grade C 11.87 -2.63% -0.32
ARCT closed down 2.63 percent on Friday, January 17, 2020, on 73 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical ARCT trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Overbought Stochastic Strength 0.00%
NR7 Range Contraction -2.63%
Overbought Stochastic Strength -2.63%
Pocket Pivot Bullish Swing Setup -2.22%
Stochastic Reached Overbought Strength -2.22%
Overbought Stochastic Strength -2.22%
Inside Day Range Contraction 0.94%
MACD Bullish Signal Line Cross Bullish -2.06%
Crossed Above 20 DMA Bullish 6.55%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.
Biopharmaceutical Pharmaceutical Industry Drugs Pharmacology Health Sciences Euphoriants Dosage Forms Cognitive Disorders Adhd Tablet

Is ARCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.5
52 Week Low 4.255
Average Volume 80,149
200-Day Moving Average 9.67
50-Day Moving Average 10.63
20-Day Moving Average 11.25
10-Day Moving Average 11.37
Average True Range 0.79
ADX 16.52
+DI 21.45
-DI 15.86
Chandelier Exit (Long, 3 ATRs ) 10.11
Chandelier Exit (Short, 3 ATRs ) 12.08
Upper Bollinger Band 12.76
Lower Bollinger Band 9.74
Percent B (%b) 0.7
BandWidth 26.82
MACD Line 0.32
MACD Signal Line 0.20
MACD Histogram 0.1194
Fundamentals Value
Market Cap 1.88 Billion
Num Shares 158 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -21.20
Price-to-Sales 11.42
Price-to-Book 2.04
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.03
Resistance 3 (R3) 13.09 12.77 12.83
Resistance 2 (R2) 12.77 12.48 12.74 12.77
Resistance 1 (R1) 12.32 12.29 12.16 12.26 12.70
Pivot Point 12.00 12.00 11.92 11.97 12.00
Support 1 (S1) 11.55 11.71 11.39 11.49 11.04
Support 2 (S2) 11.23 11.52 11.20 10.97
Support 3 (S3) 10.78 11.23 10.91
Support 4 (S4) 10.72